ARK Investment Management - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$123,480,209
-29.0%
2,993,460
-3.9%
0.94%
-17.9%
Q2 2023$173,860,560
-25.0%
3,113,549
-25.1%
1.15%
-27.7%
Q1 2023$231,825,470
+47.4%
4,155,323
-3.7%
1.59%
+16.9%
Q4 2022$157,295,701
+20.7%
4,316,567
-5.7%
1.36%
+49.9%
Q3 2022$130,348,000
-29.3%
4,576,814
+27.0%
0.91%
-16.7%
Q2 2022$184,452,000
-28.5%
3,603,286
+6.2%
1.09%
+1.3%
Q1 2022$257,979,000
-34.9%
3,391,338
+27.5%
1.08%
-10.1%
Q4 2021$396,363,000
-12.2%
2,660,866
-14.2%
1.20%
+10.5%
Q3 2021$451,582,000
-46.4%
3,101,951
-27.9%
1.08%
-30.8%
Q2 2021$842,033,000
+32.8%
4,300,037
+22.7%
1.57%
+24.4%
Q1 2021$634,246,000
+739.6%
3,504,121
+556.8%
1.26%
+526.9%
Q4 2020$75,543,000
+162.2%
533,496
+130.9%
0.20%
+17.5%
Q3 2020$28,813,000
-4.1%
231,097
-31.3%
0.17%
-47.1%
Q2 2020$30,058,000336,5530.32%
Other shareholders
10X GENOMICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders